Bio-Techne (MEX:TECH) Tariff Resilience Score: 6/10 (As of Jul. 01, 2026)


MEX:TECH Bio-Techne Corp MEX:TECH
83 GF Score
Price MXN1,090.00
GF Value MXN1,118.39
! 8 Warning Signs
View Full Analysis

What is Bio-Techne Tariff Resilience Score?

Bio-Techne MEX:TECH 83 Tariff Resilience Score is 6 as of Jul. 01, 2026. GuruFocus rates MEX:TECH with a GF Score™ of 83/100 and a GF Value™ of MXN1,118.39. The stock has 8 warning signs investors should review. Among 1,374 Biotechnology companies, Bio-Techne ranks better than 75.98% on this metric.

Bio-Techne has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Bio-Techne has Bio-Techne has a diverse global supply chain and manufacturing footprint. While it faces some exposure to tariffs on biotech products, its ability to shift production and strong pricing power mitigate risks.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Bio-Techne might have Average Resilient.

Bio-Techne  (MEX:TECH) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Bio-Techne Tariff Resilience Score Related Terms

MEX:TECH vs ARWR, CYTK, KRYS: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Bio-Techne's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Techne Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Tariff Resilience Score falls into.


MEX:TECH
83GF Score
Bio-Techne Corp MEX:TECH
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Bio-Techne (MEX:TECH) has a Tariff Resilience Score of 6 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Bio-Techne ranks #330 out of 1374 companies in the Biotechnology industry, placing it in the top 24%.
Is Bio-Techne's Tariff Resilience Score too high?
Bio-Techne's current Tariff Resilience Score is 6. The Biotechnology industry median Tariff Resilience Score is 4.00. Bio-Techne's value of 6 is 50% above this industry median. Based on the distribution chart, Bio-Techne ranks #330 out of 1374 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bio-Techne has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Tariff Resilience Score compare to ARWR and CYTK?
According to the Biotechnology industry distribution chart, Bio-Techne ranks #330 out of 1374 companies for Tariff Resilience Score. This places Bio-Techne in the top 24% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Bio-Techne's value of 6 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,374 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio-Techne's current Tariff Resilience Score of 6 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio-Techne's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current Tariff Resilience Score of 6. The stock's GF Value™ is MXN1,118.39, compared to a current price of MXN1,090.00 — trading 2.5% below its estimated fair value. The current Tariff Resilience Score is 6 and 50% above the Biotechnology industry median of 4.00. Bio-Techne's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current Tariff Resilience Score is 6 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (MEX:TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued. The current stock price of MXN1,090.00 is trading 2.5% below its estimated GF Value™ of MXN1,118.39.

Key valuation signals for MEX:TECH:

  • Tariff Resilience Score: 6
  • GF Value™: MXN1,118.39 vs. price of MXN1,090.00 (2.5% below fair value)
  • GF Score™: 83/100 with 8 warning signs
  • Industry Position: 50% above the Biotechnology median (#330 of 1374)

No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Techne Business Description

Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
83GF Score

Get the complete analysis for MEX:TECH

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,090.00
Price
MXN1,118.39
GF Value